NO306256B1 - Tricykliske 5,6-dihydro-9H-pyrazolo [3,4c]-1,2,4-triazolo [4,3-a]pyridiner, anvendelse derav og farmasöytisk preparat - Google Patents

Tricykliske 5,6-dihydro-9H-pyrazolo [3,4c]-1,2,4-triazolo [4,3-a]pyridiner, anvendelse derav og farmasöytisk preparat

Info

Publication number
NO306256B1
NO306256B1 NO962320A NO962320A NO306256B1 NO 306256 B1 NO306256 B1 NO 306256B1 NO 962320 A NO962320 A NO 962320A NO 962320 A NO962320 A NO 962320A NO 306256 B1 NO306256 B1 NO 306256B1
Authority
NO
Norway
Prior art keywords
triazolo
pyrazolo
pyridines
tricyclic
dihydro
Prior art date
Application number
NO962320A
Other languages
English (en)
Norwegian (no)
Other versions
NO962320L (no
NO962320D0 (no
Inventor
Allen Jacob Duplantier
Kelvin Cooper
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO962320D0 publication Critical patent/NO962320D0/no
Publication of NO962320L publication Critical patent/NO962320L/no
Publication of NO306256B1 publication Critical patent/NO306256B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO962320A 1995-06-06 1996-06-05 Tricykliske 5,6-dihydro-9H-pyrazolo [3,4c]-1,2,4-triazolo [4,3-a]pyridiner, anvendelse derav og farmasöytisk preparat NO306256B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002223624A CA2223624C (en) 1995-06-06 1995-06-06 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines
PCT/IB1995/000429 WO1996039408A1 (en) 1995-06-06 1995-06-06 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES
HU9601541A HUP9601541A3 (en) 1995-06-06 1996-06-05 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolol[4,3-a]-pyridines and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
NO962320D0 NO962320D0 (no) 1996-06-05
NO962320L NO962320L (no) 1996-12-09
NO306256B1 true NO306256B1 (no) 1999-10-11

Family

ID=89994031

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962320A NO306256B1 (no) 1995-06-06 1996-06-05 Tricykliske 5,6-dihydro-9H-pyrazolo [3,4c]-1,2,4-triazolo [4,3-a]pyridiner, anvendelse derav og farmasöytisk preparat

Country Status (43)

Country Link
US (1) US6004974A (ko)
EP (1) EP0837860B1 (ko)
JP (1) JP3107827B2 (ko)
KR (2) KR100191972B1 (ko)
CN (1) CN1061044C (ko)
AP (1) AP609A (ko)
AR (1) AR002745A1 (ko)
AT (1) ATE214700T1 (ko)
AU (1) AU694871B2 (ko)
BG (1) BG62568B1 (ko)
BR (1) BR9602627A (ko)
CA (1) CA2223624C (ko)
CO (1) CO4700460A1 (ko)
CZ (1) CZ287251B6 (ko)
DE (1) DE69525978T2 (ko)
DK (1) DK0837860T3 (ko)
DZ (1) DZ2044A1 (ko)
ES (1) ES2172583T3 (ko)
FI (1) FI114097B (ko)
HR (1) HRP960268B1 (ko)
HU (1) HUP9601541A3 (ko)
IL (1) IL118485A (ko)
IS (1) IS1913B (ko)
LV (1) LV11620B (ko)
MA (1) MA23893A1 (ko)
MX (1) MX9709897A (ko)
MY (1) MY116527A (ko)
NO (1) NO306256B1 (ko)
NZ (1) NZ286734A (ko)
OA (1) OA10458A (ko)
PL (1) PL184195B1 (ko)
PT (1) PT837860E (ko)
RO (1) RO115881B1 (ko)
RU (1) RU2161158C2 (ko)
SA (1) SA96170065B1 (ko)
SG (1) SG54341A1 (ko)
SI (1) SI9600186A (ko)
SK (1) SK282167B6 (ko)
TN (1) TNSN96083A1 (ko)
TR (1) TR199600482A1 (ko)
TW (1) TW460469B (ko)
WO (1) WO1996039408A1 (ko)
YU (1) YU49346B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792938B1 (fr) 1999-04-28 2001-07-06 Warner Lambert Co NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
US6326495B2 (en) * 1999-04-30 2001-12-04 Pfizer Inc. Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
EP1380585B1 (en) * 1999-04-30 2004-11-10 Pfizer Products Inc. Pyrazolopyridinone as intermediate
CA2381802C (en) 1999-08-21 2010-12-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of roflumilast and salmeterol
WO2001068600A2 (en) * 2000-03-16 2001-09-20 Inflazyme Pharmaceuticals Limited Benzylated pde4 inhibitors
MXPA03010791A (es) * 2001-05-25 2004-03-02 Boehringer Ingelheim Pharma Combinacion de inhibidor de pde4 y tiotropio a sus derivados para tratamiento de enfermedades obstructivas de vias respiratorias y de otras enfermedades inflamatorias.
JP2005508861A (ja) * 2001-05-25 2005-04-07 ファイザー・インク 閉塞性気管疾患の治療のためのｐｄｅ４阻害剤及び抗コリン性剤の組み合わせ物
GB0122031D0 (en) * 2001-09-12 2001-10-31 Pfizer Ltd Use of pde4 inhibitors in a dry powder inhaler
GB0129395D0 (en) * 2001-12-07 2002-01-30 Pfizer Ltd Pharmaceutical combination
US20050107420A1 (en) * 2002-05-23 2005-05-19 Boehringe Ingelheim Pharma Gmbh & Co. Kg Combination of a PDE4 inhibitor and tiotropium or derivative thereof for treating obstructive airways and other inflammatory diseases
WO2006075748A1 (ja) * 2005-01-17 2006-07-20 Santen Pharmaceutical Co., Ltd. アレルギー性結膜疾患治療剤
RU2008119323A (ru) 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Фармацевтические композиции мускаринового рецептора
CN102764440A (zh) 2006-07-05 2012-11-07 奈科明有限责任公司 用于治疗炎症性肺部疾病的HMG-CoA还原酶抑制剂与磷酸二酯酶4抑制剂的组合
US8653097B2 (en) * 2008-10-17 2014-02-18 Boehringer Ingelheim International Gmbh Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (P13-kinases) inhibitor
JP5730896B2 (ja) * 2009-12-04 2015-06-10 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ トリシクロピラゾール誘導体
WO2013084182A1 (en) 2011-12-08 2013-06-13 Glenmark Pharmaceuticals S.A. Pharmaceutical composition that includes a pde4 enzyme inhibitor and an analgesic agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697532A (en) * 1970-08-12 1972-10-10 Squibb & Sons Inc 5-methyldipyrazolo {8 3,4-b;3{40 ,4{40 -d{9 {0 pyridin-3(2h)-ones
HUT74170A (en) * 1993-07-06 1996-11-28 Pfizer Bicyclic tetrahydro pyrazolopyridines
CA2143143A1 (en) * 1994-03-08 1995-09-09 Toshihiko Tanaka 3-phenylpyrrolidine derivatives

Also Published As

Publication number Publication date
FI974434A (fi) 1997-12-05
YU34696A (sh) 1999-07-28
CN1142499A (zh) 1997-02-12
JP3107827B2 (ja) 2000-11-13
TNSN96083A1 (fr) 2005-03-15
CO4700460A1 (es) 1998-12-29
NZ286734A (en) 1998-02-26
RU2161158C2 (ru) 2000-12-27
PT837860E (pt) 2002-07-31
SA96170065B1 (ar) 2005-12-21
HU9601541D0 (en) 1996-07-29
MX9709897A (es) 1998-03-31
CA2223624C (en) 2001-02-20
BR9602627A (pt) 1998-09-01
CN1061044C (zh) 2001-01-24
EP0837860B1 (en) 2002-03-20
BG62568B1 (bg) 2000-02-29
MY116527A (en) 2004-02-28
KR970003440A (ko) 1997-01-28
DZ2044A1 (fr) 2002-07-21
IL118485A0 (en) 1996-09-12
PL184195B1 (pl) 2002-09-30
CA2223624A1 (en) 1996-12-12
PL314459A1 (en) 1996-12-09
KR100191972B1 (ko) 1999-06-15
FI974434A0 (fi) 1997-12-05
JPH10510242A (ja) 1998-10-06
IS1913B (is) 2004-02-03
EP0837860A1 (en) 1998-04-29
HRP960268B1 (en) 2002-12-31
IS4350A (is) 1996-12-07
OA10458A (en) 2002-03-27
DK0837860T3 (da) 2002-05-27
SK282167B6 (sk) 2001-11-06
AU5477396A (en) 1996-12-19
HUP9601541A3 (en) 1997-05-28
KR100225719B1 (en) 1999-10-15
HUP9601541A2 (en) 1997-02-28
DE69525978D1 (de) 2002-04-25
LV11620B (en) 1997-04-20
ATE214700T1 (de) 2002-04-15
RO115881B1 (ro) 2000-07-28
NO962320L (no) 1996-12-09
ES2172583T3 (es) 2002-10-01
YU49346B (sh) 2005-07-19
LV11620A (lv) 1996-12-20
AU694871B2 (en) 1998-07-30
HRP960268A2 (en) 1997-08-31
AR002745A1 (es) 1998-04-29
WO1996039408A1 (en) 1996-12-12
CZ162696A3 (en) 1997-01-15
US6004974A (en) 1999-12-21
TR199600482A1 (tr) 1997-03-21
SI9600186A (en) 1997-04-30
SK71896A3 (en) 1997-05-07
DE69525978T2 (de) 2002-12-19
SG54341A1 (en) 1998-11-16
MA23893A1 (fr) 1996-12-31
NO962320D0 (no) 1996-06-05
FI114097B (fi) 2004-08-13
AP609A (en) 1997-09-03
AP9600806A0 (en) 1996-07-31
IL118485A (en) 2000-02-17
CZ287251B6 (en) 2000-10-11
TW460469B (en) 2001-10-21
BG100640A (bg) 1997-03-31

Similar Documents

Publication Publication Date Title
NO306256B1 (no) Tricykliske 5,6-dihydro-9H-pyrazolo [3,4c]-1,2,4-triazolo [4,3-a]pyridiner, anvendelse derav og farmasöytisk preparat
IS6274A (is) Imídasó[1,2-a]pýridín og pýrasóló[2,3-a]pýridín afleiður
ZA948592B (en) 7H-imidazo[1,2-a]pyrazin-8-one derivatives,and their preparation and use
IL116774A (en) Tricyclic pyrrolobenzo diazepines and similar compounds their preparation and pharmaceutical compositions containing them
IL117621A (en) Tricyclic pyrido (3,2-e) pyrazinones their preparation and pharmaceutical compositions containing them
IL116773A0 (en) Tricyclic benzazepine compounds and their preparation
DE69427023D1 (de) Tricyclische benzazepin-und benzothiazepin derivate
IL129018A0 (en) 1H-pyrido (3,4-b) indole-4-carboxamide derivatives their preparation and application thereof in therapeutics
HU9502726D0 (en) [1,2,4]triazolo[4,3-a]qunoxaline derivatives, their preparation and use
NZ314497A (en) Pyrimido[1,2-a]indoles, intermediate and pharmaceutical compositions
IL108343A0 (en) 9H-imidazo [1,2-a] benzimidazole-3-acetamide derivatives, their preparation and their therapeutic application
EE9800174A (et) 1,4-dihüdro-1,4-diokso-1H-naftaleeni tritsükliliste derivaatide kasutamine, uued ühendid ja nende kasutamine teraapias
ZA982369B (en) Dihydropyrazino[1,2-a]indol-1-one derivatives their preparation and their use in therapy
IL110782A0 (en) Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
FR2741073B1 (fr) Derives de 4,5-dihydroimidazo(1,2-a)pyrrolo(1,2,3-cd) benzimidazole, leur preparation et leur application en therapeutique
FI952250A (fi) 5,6-dihydro-4H-tieno/3,4-c/pyrrolijohdannaiset, niiden valmistus ja terapeuttinen käyttö
HUP0002659A3 (en) Benzo-5,6-cyclohepta[1,2-b]pyridine derivatives, pharmaceutical compositions containing them and their use
AU2141595A (en) 1,2,4-triazolo{4,3-a}pyrazine-4-one derivatives, preparation thereof and drugs containing same
IL107295A (en) Bacteriorhodopsin derivatives and their preparation
IL137437A0 (en) Aminodiazepinoindoles and their use in the preparation of [1,4] diazepino [6,7,1-hi] indoles
ZA94291B (en) 9H-Imidazo(1,2-a)Benzimidazole-3-acetamide derivatives their preparation and their therapeutic application
ZA964649B (en) Tricyclic 5,6-dihydro-9H-pyrazolo[3,4c]-1,2,4-triazolo[4,3a]pyridines.
HUP9902614A3 (en) Novel n-7-heterocyclyl pyrrolo[2,3-d]pyridines and their use